Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the presentation of data from two clinical trials for PEGPH20 (pegvorhyaluronidase alfa) in patients with advanced pancreas and...

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported the results from the exploratory Phase 1b study of the gut-selective pan-Janus kinase (JAK)...

dotData, the first and only company focused on delivering end-to-end data science automation and operationalization for the enterprise, today announced the availability of Version 1.2 of its...

Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple studies of its Oncotype DX® tests highlighting their value in optimizing treatment for patients with various stages of...

The Resource Management Institute, dedicated to the advancement of resource and workforce management thought leadership, has concluded their inaugural Resource Management Global Symposium. The...

Naveris, Inc., a private biotechnology company developing blood tests for early cancer detection, congratulates Bhisham Chera, M.D. and Gaorav Gupta, M.D., Ph.D., scientific advisors and co-chairs...

ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers, announced today that it will participate in the...

Parks Associates today announced new research showing 11% of U.S. broadband households report plans to buy a smart speaker within the next 12 months. The international research firm will discuss...

HTC Corporation ("HTC"), a pioneer in innovative, smart mobile and virtual/augmented reality (VR/AR) technologies, held the HTC Vive Ecosystem Forum today at the World Conference on VR Industry...

AKnowledge Partners, LLC, a global advisory firm providing high-impact consultative strategies, solutions and advice to the world's leading executives, Fortune 1000 companies and private equity...